Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Imago BioSciences, Inc. (IMGO : NSDQ)

• Company Description    Imago BioSciences Inc. is a clinical stage biopharmaceutical company. It involved in discovering new medicines for the treatment of myeloproliferative neoplasms. Imago BioSciences Inc. is based in SOUTH SAN FRANCISCO, Calif. Number of Employees: 27

• Price / Volume Information    Yesterday's Closing Price: $15.12 Daily Weekly Monthly 20 Day Moving Average: 190,391 shares Shares Outstanding: 33.74 (millions) Market Capitalization: $510.09 (millions) Beta: 52 Week High: $35.68 52 Week Low: $12.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -14.58% -6.40% 12 Week -31.15% -25.29% Year To Date -36.23% -24.17%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 329 Oyster Point Blvd. 3rd Floor - South San Francisco,CA 94080 USA ph: 415-529-5055 fax: - laurence@gilmartinir.com http://www.imagobio.com

• General Corporate Information    Officers Hugh Y. Rienhoff - Chief Executive Officer; Director Dennis Henner - Chairman and Director Laura G. Eichorn - Chief Financial Officer Patrick Heron - Director Robert Baltera - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 45250K107 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/18/22 Share - Related Items Shares Outstanding: 33.74 Most Recent Split Date: (:1) Beta: Market Capitalization: $510.09 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.44 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.79 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/18/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.55 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -11.36% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - -36.94 12/31/21 - -59.66 09/30/21 - -66,601.30 ROA 03/31/22 - -27.17 12/31/21 - -26.42 09/30/21 - -25.75 Current Ratio 03/31/22 - 16.16 12/31/21 - 21.93 09/30/21 - 26.33 Quick Ratio 03/31/22 - 16.16 12/31/21 - 21.93 09/30/21 - 26.33 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - 5.91 12/31/21 - 6.40 09/30/21 - 6.83 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©